Jiudian Pharmaceutical: 300705 Jiudian Pharmaceutical Investor Relations Management Information 20250103
Jiudian Pharmaceutical: Announcement on the conversion of convertible corporate bonds to shares in the fourth quarter of 2024
Jiudian Pharmaceutical: 300705 Jiudian Pharmaceutical Investor Relations Management Information 20241231
Jiudian Pharmaceutical: 300705 Jiudian Pharmaceutical Investor Relations Management Information 20241225
Jiudian Pharmaceutical: 300705 Jiudian Pharmaceutical Investor Relations Management Information 20241220
Jiudian Pharmaceutical: Western Securities Report on the Company\'s 2024 Continuous Supervision and Regular Site Inspection Report
Jiudian Pharmaceutical: 300705 Jiudian Pharmaceutical Investor Relations Management Information 20241217
Jiudian Pharmaceutical: Announcement on changes in shareholders\' shares exceeding 1%
Jiudian Pharmaceutical: 300705 Jiudian Pharmaceutical Investor Relations Management Information 20241210
Jiudian Pharmaceutical: Announcement on the completion of shareholders\' share reduction
Jiudian Pharmaceutical: Announcement on the completion of shareholders\' share reduction
Jiudian Pharmaceutical: 300705 Jiudian Pharmaceutical Investor Relations Management Information 20241126
Jiudian Pharmaceutical: Announcement on share pledges for shareholders holding 5% or more of the shares
Jiudian Pharmaceutical: Progress Announcement on Providing Guarantees for Wholly-owned Subsidiaries
Jiudian Pharmaceutical: Announcement on the progress of joint investments and related transactions with professional investment institutions
Jiudian Pharmaceutical: An indicative announcement on passively diluting the shareholding ratio of shareholders holding 5% or more of the shares by more than 1%
Jiudian Pharmaceutical: 300705 Jiudian Pharmaceutical Investor Relations Management Information 20241115
Jiudian Pharmaceutical: 300705 Jiudian Pharmaceutical Investor Relations Management Information 20241108
Jiudian Pharmaceutical: Announcement on share pledges for shareholders holding 5% or more of the shares
Jiudian Pharmaceutical: Progress Notice on Withdrawal of Drug Registration Applications